Default company panoramic image

LinkCore Pharma Corp

Developer of novel anticancer therapeutics with unique healing properties targeting incurable cancers and satisfying unmet medical needs.

  • Stage Concept Only
  • Industry Healthcare Services
  • Location Vancouver, BC, Canada
  • Currency USD
  • Founded January 2003

Company Summary

LinkCore is a private Canadian company that acquires and develops novel, proprietary anticancer therapeutics with unique healing properties targeting incurable cancers and satisfying unmet medical needs. The Company projects very large ongoing revenues from its partnering/licensing arrangements.


  • Default avatar
    Radka Milanova

    Highly skilled research and development professional with over 15 years in pharmaceutical and nutraceutical arena. Accomplished senior executive with impressive international credentials in the pharmaceutical and biotechnology industries. Demonstrated outstanding leadership ability and possessed strong interpersonal and project management skills. Brings extensive experience filled with illustrious achievements in the life sciences sector driving

  • Default avatar
    Leanne Embree

    Dr. Embree joined LinkCore in 2007 as an investor and a manager after a successful twenty years career in drug research and development. Dr. Embree is responsibility for planning and directing the preclinical drug development of all the Company’s therapeutics as well as new therapeutics evaluation. Dr. Embree has a track record in drug development from bench top to clinic for novel drug formulations for the BC Cancer Agency, led and directed the

  • Default avatar
    James Kutney

    Dr. Kutney brings to LinkCore almost 40 years of experience in drug discovery, development, and scale up and manufacturing of synthetic and fermentation processes, drug evaluation and licensing. His research interests have spanned numerous areas of organic chemistry, medicinal chemistry, biotechnology and related subjects and have been the subject of over 250 scientific publications in international journals.

  • Default avatar
    Carole Berkham

    Ms Berkahn has devoted her time and efforts in the form of sweat equity with LinkCore since its creation in 2003. She brings to LinkCore a vast experience of more than 25 years in large pharmaceutical and biotechnology companies. Ms Berkahn is involved with technology search, evaluation and due diligence, filing, prosecution and maintenance of patents, contractual arrangements with CROs and others, accounting including assis


  • Default avatar
    Frasken Martineau
    Default avatar
    Pagnanini Edwards Lam